Rinri Therapeutics Ltd., United Kingdom
Dr. Gaskell graduated from the University of Edinburgh with a PhD in cell and molecular biology. She has over 20 years of expertise in life sciences research and development in both academic and industrial settings with an emphasis on the creation and use of cell- and gene-based therapeutics.
Before joining Rinri, Dr. Gaskell worked at the Cell and Gene Therapy Catapult working on the translation of several candidate therapies, including stem cell-derived treatments, in addition to supporting infrastructure and technologies.
Biolaminin® TECHNOLOGY: SUPPORTING STANDARDIZATION FOR TRANSLATIONAL SUCCESS
Thursday, July 11, 2024
6:00 PM – 6:30 PM CEST